Intrinsic Value

Returns vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock in ASM list and too much promoter holding pledged

Red Flags Found

14,803 Global Depository Receipts of the company have been delisted from the Luxembourg Stock Exchange with effect from November 15, 2021.

Orchid Pharma terminates deposit agreements with Citibank, N.A and delists GDR’s; Stock dips 2.5%

The rating on long-term bank facilities of the company has been revised to CARE BBB -; Stable.

CARE revises credit rating for bank facilities of Orchid Pharma; Stock ends 2% lower

The total number of GDRs has reduced from 32,26,688 constituting 3.63% of the total paid-up share capital to 14,803 GDRs constituting 0.04 % of the paid-up share capital of the company.

Orchid Pharma terminates deposit agreements to delist GDRs from international exchanges; Stock under pressure

Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter

Sadbhav Infrastructure Projects Ltd, Alicon Castalloy Ltd, Kothari Products Ltd and Orchid Pharma Ltd are among the other losers in the BSE’s ‘B’ group today, 05 July 2021.

Gayatri Projects Ltd leads losers in ‘B’ group

Orchid Pharma Shares Go Up 14,277%; then Crash 70%

Stocks in news: NTPC, Orchid Pharma, Ashok Leyland, Vedanta, PNB Housing, Cadila and more

The offer-for-sale in Orchid Pharma by its promoter received strong response from both non-institutional (HNI) and retail investors. While the HNI portion was subscribed by 1.14 times on Thursday, the

Orchid Pharma OFS fully subscribed

Dhunseri Tea & Industries Ltd, Orchid Pharma Ltd, G G Engineering Ltd and Gujarat Lease Financing Ltd are among the other losers in the BSE’s ‘B’ group today, 25 June 2021.

Inventure Growth & Securities Ltd leads losers in ‘B’ group

Shares of Orchid Pharma hit 10 per cent lower limit to end at Rs 1,188 on Thursday

Orchid Pharma OFS subscribed 2.5x; India Pesticides IPO 3.8x on Day 2

Stellar performances by the debutants and solid buoyancy in the sugar counters stole the show.

Biggest gainers and losers: Sugar stocks, Sona Comstar jump; Orchid Pharma tanks 10%

Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals.

Orchid Pharma Ltd

Orchid Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Orchid Pharma terminates deposit agreements with Citibank, N.A and delists GDR’s; Stock dips 2.5%

CARE revises credit rating for bank facilities of Orchid Pharma; Stock ends 2% lower

Orchid Pharma terminates deposit agreements to delist GDRs from international exchanges; Stock under pressure

Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter

Gayatri Projects Ltd leads losers in ‘B’ group

Orchid Pharma Shares Go Up 14,277%; then Crash 70%

Stocks in news: NTPC, Orchid Pharma, Ashok Leyland, Vedanta, PNB Housing, Cadila and more

Orchid Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Orchid Pharma terminates deposit agreements with Citibank, N.A and delists GDR’s; Stock dips 2.5%

CARE revises credit rating for bank facilities of Orchid Pharma; Stock ends 2% lower

Orchid Pharma terminates deposit agreements to delist GDRs from international exchanges; Stock under pressure

Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter

Gayatri Projects Ltd leads losers in ‘B’ group

Orchid Pharma Shares Go Up 14,277%; then Crash 70%

Stocks in news: NTPC, Orchid Pharma, Ashok Leyland, Vedanta, PNB Housing, Cadila and more

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock